Apr 13, 2026
Cornell researchers have taken a significant step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, with proof-of-concept results representing progress toward what's considered the 'holy grail' of male contraception.
Scientists at UCLA have developed a simple and cost-effective blood test that shows promise in early studies for detecting multiple cancers, various liver conditions, and organ abnormalities from a single blood sample.